AMNEAL PHARMACEUTICALS INC's ticker is AMRX and the CUSIP is 03168L105. A total of 169 filers reported holding AMNEAL PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 0.27 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $933,450 | +273.1% | 147,000 | -18.3% | 0.26% | +559.0% |
| Q1 2023 | $250,200 | -30.2% | 180,000 | 0.0% | 0.04% | -32.8% |
| Q4 2022 | $358,200 | -1.6% | 180,000 | 0.0% | 0.06% | -7.9% |
| Q3 2022 | $364,000 | -36.4% | 180,000 | 0.0% | 0.06% | -36.4% |
| Q2 2022 | $572,000 | -23.8% | 180,000 | 0.0% | 0.10% | -32.2% |
| Q1 2022 | $751,000 | -12.9% | 180,000 | 0.0% | 0.15% | -22.8% |
| Q4 2021 | $862,000 | -10.3% | 180,000 | 0.0% | 0.19% | -10.8% |
| Q3 2021 | $961,000 | +4.2% | 180,000 | 0.0% | 0.21% | +11.0% |
| Q2 2021 | $922,000 | -23.9% | 180,000 | 0.0% | 0.19% | -23.3% |
| Q1 2021 | $1,211,000 | +115.5% | 180,000 | +46.3% | 0.25% | +69.4% |
| Q4 2020 | $562,000 | +41.9% | 123,000 | +20.6% | 0.15% | +40.0% |
| Q3 2020 | $396,000 | -85.7% | 102,000 | -18.4% | 0.10% | -86.9% |
| Q3 2018 | $2,774,000 | -15.5% | 125,000 | -37.5% | 0.80% | -8.9% |
| Q2 2018 | $3,282,000 | – | 200,000 | – | 0.88% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fosun International Ltd | 19,552,001 | $433,859,000 | 20.80% |
| BRIDGER MANAGEMENT, LLC | 2,642,621 | $58,640,000 | 3.39% |
| TPG Group Holdings (SBS) Advisors, Inc. | 3,884,600 | $86,199,000 | 1.10% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 125,000 | $2,774,000 | 0.80% |
| HealthCor Management, L.P. | 1,036,110 | $22,991,000 | 0.76% |
| GW&K Investment Management, LLC | 2,049,765 | $45,484,000 | 0.73% |
| Bridge City Capital, LLC | 50,434 | $1,119,000 | 0.70% |
| TCW GROUP INC | 2,521,064 | $55,942,000 | 0.46% |
| FRONTIER CAPITAL MANAGEMENT CO LLC | 2,876,367 | $63,827,000 | 0.41% |
| Quadrant Capital Management, LLC | 25,002 | $555,000 | 0.35% |